The Role Of The Cell Surface Proteins Of Burkholderia

Pseudomallei In The Serodiagnosis Of Melioidosis And

Comparative Serological Proteomic Analysis Of

The Humoral Immune Response In Melioidosis by Sheik Abdul Kader, Zainoodin
 
 
THE ROLE OF THE CELL SURFACE PROTEINS OF Burkholderia 
pseudomallei IN THE SERODIAGNOSIS OF MELIOIDOSIS AND 
COMPARATIVE SEROLOGICAL PROTEOMIC ANALYSIS OF  
THE HUMORAL IMMUNE RESPONSE IN MELIOIDOSIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZAINOODIN SHEIK ABDUL KADER 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UNIVERSITI SAINS MALAYSIA 
 
2006 
 
 i
 
 
 
 
 
 
THE ROLE OF THE CELL SURFACE PROTEINS OF Burkholderia 
pseudomallei IN THE SERODIAGNOSIS OF MELIOIDOSIS AND 
COMPARATIVE SEROLOGICAL PROTEOMIC ANALYSIS OF 
THE HUMORAL IMMUNE RESPONSE IN MELIOIDOSIS 
 
 
 
 
 
 
 
by 
 
 
 
 
 
 
ZAINOODIN SHEIK ABDUL KADER 
 
 
 
 
 
 
 
 
 
Thesis submitted in fulfilment of the 
requirements for the degree 
of Doctor of Philosophy  
 
 
 
 
 
 
 
June 2006 
 
 
 
 ii
ACKNOWLEDGEMENTS 
 
 
I thank my supervisor, Professor Subramania Aiyar, for the conception of this 
dissertation project and for guidance and insightful suggestions during the course of my 
research. I thank my employer, Universiti Sains Malaysia, for the financial support and 
study leave granted to me to pursue my postgraduate study.  I also thank my co-
supervisor, Professor Asma Ismail, for all the assistance and guidance extended to me 
throughout my study period. I also thank Professor Asma Ismail for allowing me to use 
the research facilities available in MITD and for sponsoring me to attend the proteomic 
workshop at Universiti Malaya, Kuala Lumpur. I also acknowledge the Head of the 
Department of Medical Microbiology and Parasitology for the continuous support 
throughout my study. 
 
I thank my family for their long-distance support and their willingness to listen. This 
work is dedicated to my wife, my children and my parents. (I love you all). Lastly, I 
thank my wife, Faridah Mohamed, for her love, encouragement, and many 
enlightenments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iii
Table of contents 
 
 
Contents Page 
 
Acknowledgements ____________________________________________________ ii 
 
Table of contents _____________________________________________________ iii 
 
List of Figures _______________________________________________________ viii 
 
List of Tables ________________________________________________________ xii 
 
List of Presentations _________________________________________________ xiv 
 
List of Abbreviations __________________________________________________ xv 
 
Abstrak ____________________________________________________________ xvi 
 
Abstract _____________________________________________________________ xx 
 
 
Chapter 1. General Introduction _______________________________________ 1  
 
1.1 Historical perspectives and present day importance _______________________ 1 
 
1.2 Global epidemiology of melioidosis ___________________________________ 3 
 
1.3 Epidemiology of melioidosis in Malaysia _______________________________ 7 
 
1.4 General characteristics of B. pseudomallei ______________________________ 8 
 1.4.1 Classification ______________________________________________ 8 
 1.4.2 Bacteriology of B. pseudomallei ______________________________ 10 
 
1.5 Mode of transmission ______________________________________________ 14 
 
1.6 Clinical manifestations _____________________________________________ 14 
 
1.7 Pathogenesis _____________________________________________________ 18 
 
1.8 Differential diagnosis ______________________________________________ 20 
 
1.9 Antimicrobial treatment and prognosis ________________________________ 20 
 
1.10 Prevention _______________________________________________________ 23 
 
1.11 Laboratory diagnosis ______________________________________________ 24 
 1.11.1 Routine culture isolation and direct microscopic examination of 
clinical specimens _________________________________________ 24 
 1.11.2 Serological diagnosis of melioidosis ___________________________ 27 
 iv
 1.11.3 Molecular techniques for diagnosis and species differentiation ______ 31 
 
1.12 The importance of bacterial cell surface proteins (CSP) ___________________ 32 
 
1.13 Rationale for the initiation of the present study __________________________ 33 
 
1.14 The overall objectives of the present study _____________________________ 34 
 
 
Chapter 2. The usefulness of the cell surface proteins (CSP) of B. 
pseudomallei in dot Enzyme Immunoassay for rapid 
diagnosis of melioidosis ____________________________________ 39 
 
2.1 Introduction _____________________________________________________ 39 
 2.1.1 The specific objectives of this study ___________________________ 43 
 
2.2 Materials and Methods _____________________________________________ 44 
 2.2.1 Preparation of common buffers and media ______________________ 44 
 2.2.2 Bacterial culture preparation and maintenance ___________________ 44 
 2.2.3 Safety consideration ________________________________________ 45 
 2.2.4 Collection and processing of serum specimens ___________________ 45 
  2.2.4.1 Culture positive melioidosis sera ____________________ 45 
  2.2.4.2 Control sera from non-melioidosis patients ____________ 49 
  2.2.4.3 Control sera from healthy subjects ___________________ 49 
  2.2.4.4 Test sera ________________________________________ 50 
 2.2.5 Ethical approval of the study _________________________________ 50 
 2.2.6 Extraction of the CSP _______________________________________ 51 
 2.2.7 Assay for total protein content ________________________________ 52 
 2.2.8 SDS-PAGE analysis of the CSP ______________________________ 52 
  2.2.8.1 Casting of 10% mini SDS-PAGE gel _________________ 52 
  2.2.8.2 SDS-PAGE electrophoresis of the CSP _______________ 54 
 2.2.9 The Dot EIA test __________________________________________ 55 
  2.2.9.1 Preparation of nitrocellulose membrane strips __________ 55 
  2.2.9.2 Standardization of dot EIA test ______________________ 56 
  2.2.9.3 The application of the dot EIA test for serodiagnosis 
of melioidosis ___________________________________ 57 
 2.2.10  Statistical methods _________________________________________ 61 
 2.2.11 Preliminary evaluation of the standardized dot EIA test ____________ 61 
 
2.3 Results _________________________________________________________ 62 
 2.3.1 Selection of culture isolates and preparation of the CSP ____________ 62 
 2.3.2 Optimisation of the dot EIA test ______________________________ 64 
 2.3.3 Determination of the sensitivity of dot EIA test __________________ 70 
 2.3.4 Determination of the specificity of dot EIA test __________________ 77 
 2.3.5 Preliminary evaluation of the standardized dot EIA test ____________ 81 
 2.3.6 Comparison between serology and culture for early diagnosis of 
melioidosis _______________________________________________ 86 
 
2.4 Discussion and conclusions _________________________________________ 88 
 
 v
Chapter 3.  Characterization of the antigenic components in the CSP of 
B. pseudomallei by Western Blot analysis _____________________ 98 
 
3.1  Introduction _____________________________________________________ 98 
 3.1.1 The specific objectives of this study  __________________________ 101 
 
3.2 Materials and Methods ____________________________________________ 102 
 3.2.1 General purpose reagents and stock solutions ___________________ 102 
 3.2.2 Preparation of the CSP _____________________________________ 102 
 3.2.3 Serum specimens for WB analysis ____________________________ 102 
 3.2.4 SDS-PAGE separation of the CSP of B. pseudomallei ____________ 105 
  3.2.4.1 Preparation of resolving gel 10% ___________________ 105 
  3.2.4.2 Preparation of stacking gel 4.5% ____________________ 106 
  3.2.4.3 SDS-PAGE separation of the CSP __________________ 106 
 3.2.5 The WB analysis of the CSP ________________________________ 108 
 3.2.6 The WB reactive bands analysis _____________________________ 111 
 3.2.7 Interpretation of the WB results ______________________________ 111 
 
3.3 Results ________________________________________________________ 112 
 3.3.1 SDS-PAGE fractionated protein profile of the CSP for WB 
analysis _________________________________________________ 112 
 3.3.2 Characterization of major antibody isotypes response in 
melioidosis patients _______________________________________ 114 
 3.3.3 The WB analysis of IgM antibody isotype responses in culture 
positive melioidosis cases __________________________________ 126 
 3.3.4 The WB analysis of IgG antibody isotype responses in culture 
positive melioidosis cases __________________________________ 128 
 3.3.5 The WB analysis of IgA antibody isotype responses in culture 
positive melioidosis cases __________________________________ 131 
 3.3.6 The WB analysis of IgM, IgG and IgA antibody isotypes 
reactivity in sera from dot EIA test negative but culture positive 
melioidosis sera __________________________________________ 133 
 3.3.7 The WB analysis of IgM, IgG and IgA antibody isotypes 
response in sera from healthy subjects and donors _______________ 135 
 3.3.8 The WB analysis of IgM, IgG and IgA antibody isotypes 
response in non-melioidosis disease patients ____________________ 138 
 
3.4. Discussion and conclusions ________________________________________ 142 
 
 
Chapter 4.  Immunological Characterization of the CSP separated by 
Liquid phase Preparative Iso-electric Focusing and 
Analytical Polyacrylamide gel Iso-electric Focusing ___________ 152 
 
4.1 Introduction ____________________________________________________ 152 
 4.1.2 The specific objectives of this study __________________________ 156 
 
4.2 Materials and Methods ____________________________________________ 157 
 4.2.1 General buffers and solutions ________________________________ 157 
 vi
 4.2.2 Extraction of the CSP for liquid phase preparative IEF in 
Rotofor system ___________________________________________ 157 
 4.2.3 Human sera ______________________________________________ 157 
 4.2.4 Fractionation of the CSP by liquid phase preparative IEF in 
three different pH gradients by Rotofor system __________________ 158 
  4.2.4.1 Rotofor fractionation of the CSP by approach X _______ 158 
  4.2.4.2 Rotofor fractionation of the CSP by approach Y _______ 159 
 4.2.4.3 Rotofor sub-fractionation of the pooled highly 
immunoreactive fractions by approach Z _____________ 160 
 4.2.5 Analysis of the rotofor fractions by modified analytical flat bed 
mini Polyacrylamide IEF Gel (PAGE IEF) _____________________ 161 
  4.2.5.1 Casting flat bed PAGE IEF gel _____________________ 161 
  4.2.5.2 Analytical PAGE IEF gel electrofocusing of the 
rotofor fractions _________________________________ 164 
  4.2.5.3 Electrophoretic transfer of protein separated in the 
analytical PAGE IEF gel __________________________ 166 
 4.2.6 Analysis of the highly antigenic proteins in the rotofor fractions 
by SDS-PAGE and Western blotting. _________________________ 167 
  4.2.6.1 Extraction of protein from PAGE IEF gel by 
sonication _____________________________________ 167 
 4.2.6.2 SDS-PAGE electrophoresis and Western blot 
analysis of the extracted proteins from the excised 
bands _________________________________________ 168 
 
4.3 Results ________________________________________________________ 170 
 4.3.1 Fractionation of the CSP by liquid phase preparative IEF 
electrofocusing in Rotofor system ____________________________ 170 
 4.3.2 Analytical PAGE IEF immunoblot analysis of the fractionated 
CSP by preparative Rotofor system ___________________________ 177 
 4.3.2.1 Analysis of the rotofor fractions obtained by 
approach X ____________________________________ 177 
 4.3.2.2 Analysis of the rotofor fractions obtained by 
approach Y ____________________________________ 179 
 4.3.2.3 Analysis of the rotofor fractions obtained by 
approach Z _____________________________________ 181 
 4.3.3 Analysis of the highly immunoreactive bands detected in the 
rotofor fractions F16 and F7 ________________________________ 183 
4.3.3.1 Preparative PAGE IEF gel analysis of the rotofor 
fractions F16 and F7. _____________________________ 183 
4.3.3.2 SDS-PAGE analysis of the purified proteins bands 
from rotofor fraction F16 and F7. ___________________ 186 
4.3.3.3 The Western blot analysis of the purified antigens 
from fraction F16 and F7 _________________________ 188 
 
4.4 Discussion and conclusions _______________________________________ 191 
 
 
 
 
 
 vii
Chapter 5. General discussion, conclusions and future directions __________ 200 
 
5.1 General discussion and conclusions ________________________________ 200 
 
5.2  Future directions _______________________________________________ 207 
 
 
Appendices. _________________________________________________________ 209 
 
 Appendix 1  List of general chemicals and equipments ____________ 209 
 
 Appendix 2  Preparation of media, buffers and reagents for 
maintenance of stock culture and extraction of the 
cell surface proteins (CSP) of B. pseudomallei. ________ 211 
 
 Appendix 3 Preparation of the material and reagents required to 
perform the dot enzyme immunoassay (dot EIA test) ____ 212 
 
 Appendix 4 Preparation of reagents for the SDS-PAGE 
electrophoresis and Western blotting ________________ 213 
 
 Appendix 5 Preparation of the reagents for Coomassie staining 
and silver nitrate staining _________________________ 215 
 
 Appendix 6 Preparation of reagents for the preparative IEF and 
analytical IEF electrophoresis ______________________ 217 
 
 Appendix 7 Procedure for the extraction of protein from 
polyacrylamide gel by sonication ___________________ 219 
 
 Appendix 8 Ethical approval letters ___________________________ 220 
 
 Appendix 9 Abstracts for oral and poster presentations ____________ 222 
 
 
References. _________________________________________________________ 225 
 
 
 
 
 
 
 
 
 
 
 
 
 
 viii
List of Figures 
 
 
Figures  Page 
 
Figure 1.1 Schematic illustration of the experimental approach to determine 
the usefulness of cell surface proteins in dot EIA test for 
serodiagnosis of melioidosis _________________________________ 36 
 
Figure 1.2 This flowchart illustrated the application of several preparative 
and analytical separation techniques for purification, 
identification and characterization of major immunodominant 
antigens of CSP ___________________________________________ 37 
 
Figure 1.3 The flowchart for the experimental procedures for selective 
serological proteomic analysis of immunodominant antigens 
purified by preparative PAGE IEF _____________________________ 38 
 
Figure 2.1  Schematic representation of the principle of the dot EIA test for 
the detection of IgG, IgM, and IgA antibody isotypes in patient 
serum ___________________________________________________ 42 
 
Figure 2.2 Diagrammatic illustration of the stepwise procedure of the 
standardized dot enzyme immunoassay (dot EIA test) to detect 
specific IgM, IgG and IgA antibody isotypes in serum from 
melioidosis patients ________________________________________ 60 
Figure 2.3  Coomassie brilliant blue stained protein profiles of CSP 
extracted from various bacteria separated by 10% SDS-PAGE ______ 63 
 
Figure 2.4 Optimization of the dot EIA test for IgM antibody isotype 
detection _________________________________________________ 65 
  
Figure 2.5 Optimization of the dot EIA test for IgG antibody isotype 
detection _________________________________________________ 66 
  
Figure 2.6 Optimization of the dot EIA test for IgA antibody isotype 
detection _________________________________________________ 67 
 
Figure 2.7 Results of the dot EIA test for the detection of melioidosis 
specific IgM, IgG, and IgA antibody isotypes in serum 
specimens from culture positive melioidosis cases ________________ 71 
 
Figure 2.8 Representative dot EIA test results for the detection of 
melioidosis specific IgM, IgG, and IgA antibody isotypes in 
serum specimens from healthy subjects _________________________ 73 
 
Figure 3.1 Diagrammatic illustration of the WB analysis of the CSP of B. 
pseudomallei fractionated by SDS-PAGE ______________________ 110 
 ix
Figure 3.2 Coomassie brilliant blue R-250 (CBB) and silver nitrate staining 
of the protein profile in the reference lanes of the SDS-PAGE 
gels fractionated protein of the CSP prepared for WB analysis. 
Gel A was stained with CBB and gel B was stained with silver 
nitrate staining ___________________________________________ 113  
 
Figure 3.3 The representative results from the WB analysis of the serum 
IgM (M), IgG (G), and IgA (A) antibody isotypes reactivity 
against the SDS-PAGE separated antigens from the CSP of B. 
pseudomallei probed with pooled melioidosis sera (PMS), 
pooled negative control sera from healthy subjects from non-
endemic area (PHN) and individual serum from melioidosis 
patients with reference number 1-8 ___________________________ 116 
 
Figure 3.4 The representative results from the WB analysis of the serum 
IgM (M), IgG (G), and IgA (A) antibody isotypes reactivity 
profiles against the SDS-PAGE separated antigens of the CSP of 
B. pseudomallei probed with pooled melioidosis sera (PMS), 
pooled negative control sera from healthy subjects from non-
endemic area (PHS) and individual serum from melioidosis 
patients with reference number 9-16 __________________________ 117 
 
Figure 3.5 The representative results from the WB analysis of the serum 
IgM (M), IgG (G), and IgA (A) antibody isotypes reactivity 
against the CSP antigens in WB assay probed with individual 
serum from melioidosis patients with reference number 17 –26 _____ 118 
 
Figure 3.6 The representative results from the WB analysis of the serum 
IgM (M), IgG (G), and IgA (A) antibody isotypes reactivity 
against the CSP antigens in WB assay probed with individual 
serum from melioidosis patients with reference number 27 – 35 ____ 119 
 
Figure 3.7 This figure also shows the representative results from the WB 
analysis of the serum IgM (M), IgG (G), and IgA (A) antibody 
isotypes reactivity against the CSP antigens in  the WB assay 
probed with additional 5 individuals sera from melioidosis 
patients with reference number 36 – 40 ________________________ 120 
 
Figure 3.8 The representative results from the WB analysis of the serum 
IgM (M), IgG (G) and IgA (A) antibody isotypes reactive bands 
recognized by 5 more sera from melioidosis patients with 
reference number 41 – 45 ___________________________________ 121 
 
Figure 3.9 This figure also shows the reactivity of the serum IgM (M), IgG 
(G) and IgA (A) antibody isotypes against the CSP antigens in 
the WB assay probed with serum from individual melioidosis 
patients with reference number 46 - 52 ________________________ 122 
 
 
 
 x
Figure 3.10 The results from the WB analysis of the serum IgM (M), IgG 
(G) and IgA (A) antibody isotypes reactivity against the CSP 
antigens in the WB assay probed with the representative sera 
from culture negative melioidosis patients diagnosed based on 
positive serology and supportive evidence from clinical findings 
for melioidosis infection ___________________________________ 125 
 
Figure 3.11 Summary of the WB analysis of melioidosis specific IgM 
antibody isotype reactivity in culture confirmed melioidosis sera 
against the antigenic component in the CSP ____________________ 127 
 
Figure 3.12  Summary of the WB analysis of melioidosis specific IgG 
antibody isotype reactivity in the culture confirmed melioidosis 
sera against the antigenic components in the CSP ________________ 130 
 
Figure 3.13  Summary of the WB analysis of melioidosis specific IgA 
antibody isotype reactivity in the culture confirmed melioidosis 
sera against antigenic component in the CSP ___________________ 132 
 
Figure 3.14 Analysis of IgM, IgG and IgA antibody isotypes reactivity in the 
WB assay probed with dot EIA test positive pooled sera from 
healthy subjects, PHS, pooled sera from donors, PDS and pooled 
sera from melioidosis patients, PMS __________________________ 137 
 
Figure 3.15 This figure shows the IgM, IgG and IgA antibody isotypes 
reactivity in the WB assay against the CSP antigens probed with 
three pooled sera from non-melioidosis cases ___________________ 140  
 
Figure 3.16 Summary of the overall view of humoral immune response in 
the pools of serum from melioidosis and non-melioidosis cases 
against the antigens in the CSP of B. pseudomallei analyzed by 
the WB assay. The IgM, IgG and IgA antibody isotypes 
response displayed by each serum pool were shown in the 
schematic diagram (a), (b) and (c), respectively _________________ 141 
 
Figure 4.1  Characterization of the CSP by combined fractionation in liquid 
phase preparative IEF and analytical gel phase IEF followed by 
IEF immunoblotting _______________________________________ 155 
 
Figure 4.2 Preparation of analytical PAGE IEF gel. The figure shows in 
diagrammatically the arrangement of glass plate and casting tray 
used for preparing of the IEF gel for analytical isoelectric 
focusing analysis of the rotofor fractions _______________________ 163 
 
Figure 4.3 Analytical Polyacrylamide gel IEF electrofocusing. The figure 
shows in sequential order the protocol to perform PAGE IEF 
electrofocusing ___________________________________________ 165 
 
 xi
Figure 4.4 CBB stained protein profiles in the analytical PAGE IEF gel 
analysis of the 20 rotofor fractions obtained from the 
fractionation of the CSP in preparative IEF by approach X ________ 171 
 
Figure 4.5 Silver nitrate stained protein profiles in the analytical PAGE IEF 
gel analysis of the 20 rotofor fractions obtained from the 
fractionation of the CSP in preparative IEF by approach X ________ 172 
 
Figure 4.6 CBB stained analytical PAGE IEF gel analysis showing the 
electrofocusing of the 20 rotofor fractions obtained from the 
fractionation of the CSP by approach Y _______________________ 174 
 
Figure 4.7 The silver nitrate stained protein profiles in analytical PAGE IEF 
gel analysis of the 20 rotofor fractions obtained from the 
refractionation of the pooled selected rotofor fractions by 
approach Z ______________________________________________ 176 
 
Figure 4.8 Analytical PAGE IEF immunoblot analysis of the CSP 
fractionated in preparative Rotofor system by approach X (pH 
gradient 3 to 10) and probed with pooled melioidosis sera _________ 178 
 
Figure 4.9 Analytical PAGE IEF immunoblot analysis of the CSP 
fractionated in preparative Rotofor system by approach Y (pH 
gradient 4.5 to 5.9) and probed with pooled melioidosis sera _______ 180 
 
Figure 4.10 Analytical PAGE IEF immunoblot analysis of the CSP 
fractionated in preparative Rotofor system by approach Z and 
probed with pooled melioidosis sera __________________________ 182 
 
Figure 4.11 Preparative PAGE IEF gel analysis of rotofor fraction F16 
visualised by CCB staining. The fraction F16 represents the 
major immunoreactive fraction obtained from rotofor 
fractionation of the CSP by approach Y _______________________ 184 
 
Figure 4.12 CCB stained preparative PAGE IEF gel analysis of the 
immunodominant rotofor fraction F7. The fraction F7 represents 
the major immunoreactive fraction obtained from rotofor 
fractionation of the CSP by approach Z ________________________ 185 
 
Figure 4.13 A silver nitrate stained SDS-PAGE gel showing the proteins 
found in the selected bands extracted from rotofor fraction F16 
and F7 __________________________________________________ 187 
 
Figure 4.14 The WB analysis of the purified proteins obtained from rotofor 
fraction F6 and F7. The purified proteins were separated by 10% 
SDS-PAGE and subjected to WB assay ________________________ 189 
 
 
 
 xii
List of Tables 
 
 
Tables Page 
 
Table 1.1 Biochemical reactions for identification and differentiation of B. 
pseudomallei from the related species in the genus Burkholderia. 
Adapted from Zysk et. al. (2000) ______________________________ 12 
 
Table 1.2 Performance of various antibody detection assays in 101 
patients. Adapted from Sirisinha et al. (2000) ____________________ 30 
 
Table 2.1 Isolates used in this study and the respective patient disease 
profile ___________________________________________________ 45 
 
Table 2.2 The table showing the details of sera obtained from culture 
positive melioidosis cases used in this study _____________________ 47 
 
Table 2.3 Distribution of the specific IgM, IgG and IgA antibody isotypes 
(a) and (b) against the CSP of B. pseudomallei in the sera obtained from 65  
 culture positive melioidosis cases detected by dot EIA test            
 at 1:100 dilution ___________________________________________ 75 
 
Table 2.4 Evaluation of the specificity of the dot EIA test performed           
 (a) against control groups comprising of healthy subjects and                  
  diseased subjects confirmed for variety of infections by                
  culture or serological methods ________________________________ 78 
 
Table 2.4 Evaluation of the specificity of the dot EIA test performed       
(b) and (c) against control groups comprising of healthy subjects and             
 diseased subjects confirmed for variety of infections by                
 culture or serological methods ________________________________ 79 
 
Table 2.5 Detection of specific IgM, IgG and IgA antibody isotypes 
against the CSP of B. pseudomallei in clinical specimens 
received for melioidosis serology. The relevant clinical findings 
for each patient were also indicated ____________________________ 83 
 
Table 2.6 Preliminary analysis of the distribution of the IgM, IgG and IgA 
(a) and (b)  antibody isotypes against the CSP of B. pseudomallei in the 60    
 representative clinical cases of melioidosis tested positive by the   
 dot EIA test ______________________________________________ 85 
 
Table 2.7 Preliminary comparative analysis of the performance of the dot 
EIA test and the routine culture method in rapid diagnosis of 
melioidosis _______________________________________________ 87 
 
Table 3.1 The dot EIA test results for the culture positive melioidosis sera 
selected for further analysis by WB assay ______________________ 103 
 xiii
Table 3.2 The various categories of the pooled sera derived from 
melioidosis, non-melioidosis and healthy subjects for the WB 
assay. The positive results for dot EIA test denote the present of 
IgM, IgG or IgA antibody isotypes alone or in a combination 
against the CSP antigens of B. pseudomallei ____________________ 105 
 
Table 3.3 Frequency of recognition of the antigenic bands present in the 
CSP of B. pseudomallei by sera from culture positive 
melioidosis cases analyzed by the WB assay ____________________ 123 
 
Table 3.4 The WB analysis of melioidosis specific IgM, IgG and IgA 
antibody isotypes reactivity against the CSP antigens detected in 
the dot EIA test negative culture confirmed melioidosis sera _______ 134 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xiv
List of Presentations 
 
The research findings arising from the experimental works carried out in this thesis 
were presented in part as a preliminary report at the following conferences. 
 
 
Oral presentation 
 
1. Sheik Abdul Kader, Z., Aiyar, S. and Ismail, A. The Use of the Cell Surface 
Proteins of Burkholderia pseudomallei in Dot Immunoassay for the Serodiagnosis of 
Melioidosis. Paper presented at the “International Congress on Melioidosis: State of the 
Art Discoveries and Trends towards the 21st Century”. Siam City Hotel, Bangkok, 
Thailand. November 22-25, 1998.  
 
2. Sheik Abdul Kader, Z., Aiyar, S. and Ismail, A. Characterization and Comparative 
analysis of Antigenic Components of the Cell Surface Proteins of Burkholderia 
pseudomallei. Paper presented at the “World Melioidosis Congress”. Burswood 
International Resort Convention Centre, Pert, Australia. September 26th – 29th, 2001. 
 
3. Sheik Abdul Kader, Z., Aiyar, S. and Ismail, A. Serodiagnosis of Melioidosis: A 
Laboratory Perspective. Paper presented at the “National Diagnostic Conference and 
Workshop: Opportunities and Challenges in Medical Diagnostic Research”. 
Renaissance Kota Bharu Hotel, Kelantan, Malaysia. October 4th – 7th, 2004.   
 
 
Poster presentation 
 
Sheik Abdul Kader, Z. and Aiyar, S. The Efficacy of the Cell Surface Proteins of 
Burkholderia pseudomallei in the Serodiagnosis of Melioidosis. Poster presented at the 
“7th Western Pacific Congress of Chemotherapy and Infectious Diseases: Meeting the 
Challenges of the New Millennium”. Hong Kong Convention and Exhibition Centre, 
Hong Kong SAR, China. December 11th – 14th, 2001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xv
List of Abbreviations 
 
2-D Two-dimension electrophoresis 
AP Alkaline phosphatase 
BCIP C1-5-bromo-4-chloro-3-indolylphosphate p-toluidine  
BSL3 Biosafety level 3 laboratory 
CBB  Coomassie brilliant blue  
CFA Culture filtrate antigen 
CSP Cell surface proteins 
DNA Deoxyribonucleic acid 
Dot EIA Dot enzyme immunoassay 
HIV Human immunodeficiency virus 
IEF Iso-electric focusing 
IFA Indirect immunofluorescence antibody assay   
IgA  Immunoglobulin A   
IgG  Immunoglobulin G 
IgM Immunoglobulin M 
IHA Indirect hemagglutination assay 
kDa  kilodalton 
LPS  Lipopolysaccharide 
MAPIA Multi Antigen Print Immuno Assay 
NBT Nitroblue tetrazolium 
NC Nitrocellulose membrane 
PAGE IEF Polyacrylamide gel iso-electric focusing 
PCR   Polymerase chain reaction 
pI Iso-electric point  
rRNA Ribosomal ribonucleic acid 
SARS Severe acute respiratory syndrome  
SDS-PAGE Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
TBS Tris-buffered saline   
TBS-SM Tris-buffered saline-skim milk 
Tris  Tris(hydroxymethyl)aminomethane 
WB Western blot 
www World Wide Web 
 
 
 
 
 
 
 
 
 
 
 xvi
PERANAN PROTEIN PERMUKAAN SEL Burkholderia pseudomallei 
DALAM SERODIAGNOSIS PENYAKIT MELIOIDOSIS DAN 
PERBANDINGAN TINDAKBALAS IMMUN HUMORAL  
DALAM PENYAKIT MELIOIDOSIS MELALUI KAJIAN 
SEROLOGIKAL PROTEOMIK 
 
 
 
Abstrak 
 
 
Melioidosis adalah penyakit di kalangan manusia dan haiwan yang disebabkan oleh 
jangkitan bakteria, Burkholderia pseudomallei. Manifestasi klinikal penyakit ini amat 
rencam dan boleh berubah daripada keadaan yang tidak merbahaya kepada jangkitan 
teruk yang melibatkan anggota-anggota dalaman dan sekiranya tidak dirawat dengan 
segera boleh membawa maut. Kes akut perlukan rawatan dengan antibiotik yang sesuai 
untuk jangka waktu yang lama untuk mengelakkan jangkitan berkekalan (persistence) 
dan jangkitan berulang (relapse). Diagnosis klinikal selalunya tidak tepat disebabkan 
manifestasi klinikal yang tidak spesifik. Diagnosis makmal bergantung kepada kaedah 
pengkulturan dan pemencilan bakteria daripada spesimen klinikal. Kaedah pengkulturan 
kekal sebagai kaedah pilihan tetapi ia tidak sensitif dan memakan masa. Dalam dua 
dekad yang lalu, beberapa kajian untuk menghasilkan ujian serologi yang berkualiti 
untuk diagnosis segera melioidosis telah dilaporkan. Hasil daripada usaha ini kurang 
memuaskan.  
 
Dalam kajian ini antigen protein daripada permukaan sel bakteria (CSP), B. 
pseudomallei, dengan dua kepekatan yang optimum telah digunakan untuk 
menghasilkan ujian enzim immuno titik (‘dot enzyme immunoassay’, ‘dot EIA’). 
Protokol ujian ‘dot EIA’ yang piawai telah diwujudkan untuk diagnosis segera penyakit 
melioidosis akut dengan mengesan serentak kehadiran antibodi isotip IgM, IgG dan IgA 
dalam serum pesakit. Nilai sensitiviti yang diperolehi untuk mengesan setiap antibodi 
 xvii
isotip adalah seperti berikut: 47.7% untuk IgM, 89.2% untuk IgG dan 60% untuk IgA. 
Kualiti ujian ini bertambah baik apabila keputusan untuk ujian IgM, IgG dan IgA 
digabungkan di mana, sensitiviti meningkat kepada 95.5% dan spesifisiti meningkat 
kepada 92.5%. Dalam kajian prospektif, kes-kes melioidosis yang baru berjaya dikesan 
dan disahkan dengan ujian ‘dot EIA’ atas spesimen serum yang diambil daripada 
pesakit yang disyaki melioidosis. Kajian ini adalah yang pertama membuktikan potensi 
antigen CSP daripada B. pseudomallei untuk digunakan dalam ujian ‘dot EIA’ untuk 
diagnosis segera penyakit melioidosis dengan mengesan kehadiran antibodi isotip IgM, 
IgG dan IgA dalam serum pesakit. 
 
Percirian antigen CSP dengan kaedah ‘Western blot’ (WB) konvensional telah 
mengesan tindakbalas serum melioidosis terhadap 25 jalur antigen dengan intensiti dan 
frekuensi yang berbeza. Keputusan perbandingan profil jalur-jalur antigen yang 
dihasilkan oleh 55 serum daripada pesakit melioidosis menunjukkan tiada satu profil 
jalur antigen yang mempunyai ciri-ciri diagnostik untuk melioidosis. Keputusan ini 
menggambarkan tindakbalas immun humoral pesakit melioidosis dalam jangkamasa 
jangkitan berbeza dengan ketara terhadap antigen-antigen yang terdapat dalam CSP. 
Profil protein antigenik yang dikesan dengan ujian WB konvensional telah 
dikategorikan dalam tiga kelompok. Kelompok 1 terdiri daripada jalur-jalur antigen 
yang berbentuk kembang dan tebal (‘broadly diffused bands’) dengan berat molekul 
antara 43 kDa hingga 36.8 kDa. Kelompok kedua merangkumi jalur-jalur antigen yang 
tersusun rapi (regularly spaced) dengan berat molekul 35.6 kDA hingga 25 kDa. 
Kelompok ketiga merangkumi jalur-jalur dengan berat molekul yang rendah iaitu antara 
22 kDa hingga 13.2 kDa. Serum daripada subjek normal dan pesakit bukan melioidosis 
dari kawasan endemik menunjukkan tindakbalas silang yang agak ketara terhadap 
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antigen dalam kelompok 1 dan tindakbalas silang yang terbatas terhadap antigen dalam 
kelompok 2 dan 3. Ini menunjukkan individu yang sihat dan pesakit bukan melioidosis 
dari kawasan endemik mempunyai antibodi terhadap antigen CSP dan memiliki 
immuniti pada tahap yang signifikan terhadap melioidosis.Walaupun tindakbalas sera 
daripada kes melioidosis dan kes bukan melioidosis tidak dapat dibezakan dalam ujian 
WB terutamanya tindakbalas terhadap antigen dalam kelompok 1, perbezaan 
tindakbalas serum-serum ini pada peringkat epitop perlu ditentukan.  
 
Dalam kajian serologikal proteomik, pemfokusan isoelektrik (IEF) dengan kaedah 
preparatif Rotofor IEF dan analitikal poliakrilamida gel IEF (PAGE IEF) telah 
digunakan untuk pencirian protein CSP berdasarkan kepada cas molekul. Pemisahan 
CSP dengan sistem preparatif Rotofor IEF telah menghasilkan 20 fraksyen rotofor. Satu 
keadah baru analisis immunoblot protein yang dipisahkan dengan kaedah PAGE IEF 
telah diwujudkan. Ujian immunoblot PAGE IEF yang telah dilakukan terhadap 20 
fraksyen rotofor dengan serum melioidosis yang disatukan (pooled sera) menunjukkan 
kehadiran jalur antigen pada lokasi yang mempunyai nilai anggaran pI 4.0 hingga 6.5. 
Profil jalar-jalur antigen ini adalah yang berbentuk kembang, tebal dan beberapa jalur 
yang jelas (well defined bands). Analisis awal telah dijalankan ke atas fraksyen F16 dan 
F7 yang dipilih daripada fraksyen-frakyen rotofor yang reaktif untuk mengenalpasti 
kandungan protein dengan kaedah PAGE IEF. Protein yang telah dipurifikasi dalam 
matrik gel telah diekstrak dengan kuantiti yang banyak melalui sonikasi untuk kajian 
selanjutnya. Analisis awal dengan kaedah SDS-PAGE ke atas protein yang telah 
diekstrak menunjukkan kewujudan protein ‘isoform’ dan kejayaan dalam 
memperkayakan protein antigenik yang terdapat dalam jumlah yang sedikit serta 
terlindung dalam CSP. Kehadiran protein seperti ini tidak dapat dikesan dengan kaedah 
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WB konvensional. Protein ini juga telah menunjukkan tindakbalas yang kuat dan 
spesifik dengan serum melioidosis yang disatukan. Protein yang antigenik ini boleh 
digunakan bersama-sama dengan protein antigenik dalam CSP yang dikenalpasti 
melalui kaedah WB konvensional untuk menghasilkan ujian diagnostik multi-antigen 
yang lebih baik untuk penyakit melioidosis.  
 
Kesimpulanya, kerja penyelidikan ini amat berguna untuk mewujudkan ujian serologi 
baru untuk diagnosis penyakit melioidosis. Selain itu, ia juga membina asas yang amat 
berguna untuk mengenal pasti mekanisme patologik dalam penyakit melioidosis, untuk 
mengenalpasti dan mendedahkan lebih banyak antigen untuk kegunaan diagnostik dan 
penghasilan vaksin untuk melioidosis. 
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THE ROLE OF THE CELL SURFACE PROTEINS OF Burkholderia 
pseudomallei IN THE SERODIAGNOSIS OF MELIOIDOSIS AND 
COMPARATIVE SEROLOGICAL PROTEOMIC ANALYSIS OF 
THE HUMORAL IMMUNE RESPONSE IN MELIOIDOSIS 
 
 
 
Abstract 
 
 
Melioidosis refers to an infection by the bacterium, B. pseudomallei, affecting man and 
animals. Clinical manifestations are protean, ranging from mild and self-limited 
diseases to progressive multi-organ infection with fatal consequences, if untreated. 
Treatment with prolonged course of antibiotics is required for the acute infection and 
the prevention of development of persistence of infection and relapse. The diagnosis 
based on clinical evidence is a challenging task, as the presenting symptoms mimic 
many other common infectious diseases. Direct isolation remains the mainstay in the 
laboratory diagnosis for melioidosis although it is less sensitive and time consuming. 
Over the last two decades, many experimental approaches towards the development of a 
reliable serological assay for rapid serodiagnosis of melioidosis have been reported. 
However, these attempts were often met with limited success.  
 
In the present study, a standardized protocol of dot enzyme immunoassay (dot EIA test) 
with two optimized concentrations of the cell surface proteins (CSP) antigens from B. 
pseudomallei was established for serological diagnosis of melioidosis by detecting the 
IgM, IgG and IgA antibody isotypes as markers for current infection. The sensitivity of 
the dot EIA test for the detection of IgM, IgG and IgA antibody isotypes individually 
were 47.7%, 89.2% and 60% respectively.  However, the overall combined detection of 
the IgM, IgG and IgA antibody isotypes improved the sensitivity and specificity of the 
dot EIA test to 95.5% and 92.5%, respectively. In addition, the dot EIA performed 
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satisfactorily in the prospective study for the diagnosis of melioidosis by detecting the 
IgM, IgG and IgA antibody isotypes in the sera tested from clinically suspected cases of 
melioidosis. The preliminary finding from this study demonstrated for the first time the 
potential use of the CSP of the B. pseudomallei as a source of antigens in the dot EIA 
test for early and accurate diagnosis of melioidosis by detecting the IgM, IgG and IgA 
antibody isotypes in the patient’s serum.  
 
Characterization of the SDS-PAGE separated CSP antigens by conventional Western 
blot (WB) analysis revealed 25 antigenic bands recognized by melioidosis sera with 
variable frequency and intensity. When the patterns of the antigenic bands were 
compared between the 55 sera from melioidosis patients, no single pattern was found to 
be diagnostically adequate. Great diversity in the humoral immune response against the 
CSP antigens was observed in each of the melioidosis patient during the time course of 
the infection. The heterogeneous antigenic protein profiles observed in the WB assay 
were categorized into three clusters of antigens. These included broadly diffused 
antigenic bands with the molecular weights ranging from 43 kDa to 36.8 kDa (cluster 
1), regularly spaced antigenic bands with molecular weights ranging from 35.6 kDa to 
25 kDa (cluster 2), and low molecular weights antigenic bands with molecular weights 
ranging from 22 kDa to 13.2 kDa (cluster 3). Some degree of comparable cross-reaction 
was observed between normal sera and non-melioidosis patients sera from endemic 
regions against the antigens in cluster 1. However, the endemic sera showed very 
limited cross-reactions with the antigens in the clusters 2 and 3. These data suggested 
that healthy individuals and non-melioidosis patients in endemic regions possessed 
antibodies specific to the CSP reflecting significant degree of background immunity to 
melioidosis. Although the reactivity of the non-melioidosis and melioidosis sera were 
 xxii
not distinguishable in the WB analysis especially against the antigens in the cluster 1, 
whether the non-melioidosis and melioidosis sera recognized similar and different 
epitopes present in the same antigens remains to be elucidated. 
 
In serological proteomic study, the CSP was fractionated based on molecular charge in 
preparative Rotofor isoelectric focusing (IEF) and polyacrylamide gel IEF (PAGE IEF). 
Fractionation in the preparative Rotofor IEF produced 20 rotofor fractions. A new 
protocol to perform immunoblotting of the proteins separated by PAGE IEF gel was 
developed. The IEF immunoblot analysis of the 20 rotofor fractions with pooled 
melioidosis sera demonstrated presence of several strongly reacting bands located at the 
pI values approximately 4 to 6.5. Preliminary analysis was performed to determine the 
antigenic composition in the selected reactive rotofor fractions number F16 and F7 by 
PAGE IEF method. The fractionated proteins in the gel matrix were extracted in 
adequate quantity by sonication for subsequent analysis. Preliminary analysis by SDS-
PAGE of the extracted proteins revealed the existence of the isoforms protein antigens 
and successful enrichment of the hidden low abundance antigenic proteins present in the 
CSP that otherwise may not be possible to detect by the conventional WB analysis. The 
purified proteins extracted from the selected fractions from IEF study showed strong 
and specific reaction with pooled melioidosis sera. These antigens can be used along 
with the antigens identified by the conventional WB assay of the CSP separated by 
SDS-PAGE to develop an improved multi-antigens based diagnostic assay for 
melioidosis. 
 
In summary, this work would clearly be relevant for the development of newer serologic 
tests for diagnosis for melioidosis. Elucidation of the pathological mechanism in 
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melioidosis disease progression and recovery, exposition of more antigenic components 
for diagnostic application and development of vaccine for melioidosis would be other 
spin offs.  
Chapter 1 
 
General Introduction 
 
1.1 Historical perspectives and present day importance of melioidosis 
 
Melioidosis is an environmental related and potentially fatal bacterial infectious disease 
involving multi-organ systems of man and wide range of domestic and wild animals. It 
is caused by a soil saprophyte, Burkholderia pseudomallei (Chaowagul et al., 1989, 
Leelarasamee & Bovornkitti, 1989, Sanford, 1995, Choy et al., 2000, Josephson, 2001, 
Dance, 2002, O'Brien et al., 2003). Documented historical evidence frequently quoted 
in the medical text and literature showed that a British surgeon, Captain A. Whitmore 
and his assistant, C.S. Krishnaswami were responsible for reporting the first case of 
melioidosis in Rangoon, the capital city of Myanmar (formerly known as Burma) in 
1911 (Dance, 1991a, Sanford, 1995). These two medical professionals pioneered the 
historical discovery of melioidosis following a mysterious outbreak among the drug 
addicts. During routine postmortem work out, they discovered the presence of multiple 
abscesses mainly in the lungs, the liver, the spleen, and the kidneys in the dead bodies 
of the intravenous-drug abusers. The pathological features were noted to resemble 
glanders, an infectious disease caused by the bacterium, Burkholderia mallei. At that 
point of time, glanders was a well-recognized infectious disease of animals primarily in 
horses. They performed detailed clinical and bacteriological investigations following 
classic Koch postulate approach to resolve the unusual findings observed during the 
postmortem. They concluded the investigations with a report that described the 
pathology of the disease, the etiological agent and its clear distinction between glanders. 
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They also named the new agent as Bacillus pseudomallei and the disease was described 
as pseudoglanders (Howe et al., 1971, Sanford, 1995). Shortly in 1913, Stanton and 
Fletcher from the United States Army Medical Research Unit at the Institute for 
Medical Research in Kuala Lumpur had reported severe distemper-like outbreak among 
the laboratory animals (Dance, 1991a). Subsequently in 1921, Stanton and Fletcher 
ascribed the infection to B. pseudomallei. They introduced the term melioidosis to 
collectively describe the entire clinical presentations arising from infection by B. 
pseudomallei. The term was derived from the Greek word in which ‘melis’ means ‘a 
distemper of asses’ and ‘eidos’ means resemblance (Dance, 1991a). Following these 
two historical records concerning melioidosis, only a few sporadic cases had been 
reported from various countries from the South-East Asia.  The disease was not given 
priority compared to other well known infectious diseases at that point of time. 
Furthermore, in routine medical microbiology laboratories B. pseudomallei frequently 
isolated from clinical specimens was considered as contaminant. 
 
During the military conflict in Indochina in the sixties, the occupying armies from 
United States of America and France apparently suffered significant loses due to 
melioidosis (Sanford & Moore, 1971, Dance, 1991a, Neel, 1991). Variability in clinical 
presentation, difficulties in concluding prompt laboratory diagnosis, and treatment 
complication with poor prognosis of melioidosis, were among the challenges faced by 
the medical professionals of the occupying armies in managing the soldiers during the 
wars (Dance, 1991a). This war marked the global resurgence of interest in melioidosis. 
The high incidence of melioidosis reported during the war associated with broad 
spectrum of clinical manifestations have evoked the scientific community and military 
authorities of the countries involved in the war to search for solutions to all aspects of 
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the melioidosis. Melioidosis also caused considerable concern to the military 
communities due to reports that it had potential to be used as biological warfare agent 
(Klietmann & Ruoff, 2001, Bruce, 2003). Currently extensive research is being carried 
out by scientist throughout the world for solution to the challenges and problems posed 
by melioidosis. As a result, International Congresses on Melioidosis have been held in 
Malaysia, Thailand and Australia in 1994, 1998 and 2002, respectively. 
 
1.2 Global epidemiology of melioidosis 
 
Melioidosis fall in the category of re-emerging infectious disease that poses a global 
threat to man and animals (Dance, 2000c). Sporadic cases and outbreaks are 
continuously being reported in the communities residing in the endemic regions. The 
global distributions of melioidosis by and large are restricted to tropical and subtropical 
regions especially in Southeast Asia and northern Australia as usually cited in several 
reviews and medical text. However, an alarming number of sporadic cases of 
melioidosis have increasingly been reported from non-endemic regions throughout the 
world. Several confirmed cases of melioidosis have been reported to occur in Taiwan, 
mainland of China and Hong Kong, Laos, Cambodia, Brunei, Vietnam, India, 
Bangladesh, Sri Lanka, Pakistan, Central and South America, North America, Africa, 
and the Middle East (Kang et al., 1996, Dorman et al., 1998, Parry et al., 1999, Dance, 
2000c, Yang, 2000, Hsueh et al., 2001). Therefore the distribution of the disease is had 
not been restricted to the traditional endemic regions (Dance, 2000c, White, 2003). The 
boundaries of endemic regions are expanding out of the tropical and subtropical regions. 
Occurrences of melioidosis in non-endemic areas were largely due to increase mobility 
of people throughout the world and influx of immigrants from endemic to non-endemic 
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areas (Dance et al., 1999). The disease was also recognised as potential health hazard to 
tourist and diplomat in the endemic countries (Thummakul et al., 1999, Leelarasamee & 
Bovornkitti, 2001, Riesland et al., 2001).  
 
During the conclusion of the Vietnam war, serological survey conducted on war 
veterans showed the presence of low-titer hemagglutinating antibodies to melioidosis in 
as many as 225,000 US army veterans (Sanford & Moore, 1971, Bruce, 2003). Late 
onset of incidence of melioidosis associated with recrudescence had been reported from 
this group of infected veterans (Chodimella et al., 1997). Small scale outbreaks had 
been reported in Brazil indicating wide spread occurrence of melioidosis throughout the 
world (ProMed-mail, 2003). 
 
The incidence of the disease has increased over the last two decades in the traditional 
endemic regions that comprised of Singapore, Australia, Malaysia and Thailand. One 
reason for this could be the increased awareness of the disease among the medical and 
laboratory professionals. Other contributing factors would include the implementation 
of effective disease surveillance, improved diagnostic tools for effective laboratory 
isolation and identification, and mandatory disease notification. 
 
The incidence in humans ranges widely between different endemic regions. There are 
several comprehensive reviews reported in the literature that described in detail the 
epidemiological investigations carried out in endemic and non-endemic regions 
throughout the world (Lim, 1997, Leelarasamee, 1998, Dance, 2000c, Finkelstein et al., 
2000, Leelarasamee, 2000, Faa & Holt, 2002, Cheng et al., 2003). Incidence of 
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nosocomial infection associated with melioidosis also have been reported (Ashdown, 
1979, White, 2003). 
 
The epidemiological data also pointed out that the incidences of melioidosis were 
largely from tropical and subtropical regions with variable intensity of infection within 
and between the endemic countries. Variable intensity of infection within the endemic 
zone was attributed to segregated distribution of B. pseudomallei in the endemic area 
(Finkelstein et al., 2000). Epidemiological surveys also identified the existence of two 
hyperendemic regions within the tropical zone, which comprised of the ‘Top End’ of 
the Northern Territory in Australia and Ubon Ratchatani and Khon Kaen provinces in 
north-east Thailand. Melioidosis was assigned as the most common community 
acquired infection in these two regions. 
 
Incidences of melioidosis in Australia by and large are confined to the tropical regions 
which include Northern Territory, north Queensland, Torres Strait Islands and Western 
Australia (Currie et al., 2001, Edmond et al., 2001, Faa & Holt, 2002, Cheng et al., 
2003). Imported cases were reported in the temperate zone within this country (Wilson 
et al., 1987). Epizootic incidences of animal melioidosis was found to be responsible for 
significant economic consequences in the livestock industry (Choy et al., 2000). For the 
last two decades, the incidence of human infection was noted to be increasing in 
number. 
 
In one study conducted in Torres Strait islands between 1995 and 2000 a total of 23 
cases of melioidosis which represented a mean annual incidence rate of 42.7 per 
100,000 population has reported (Faa & Holt, 2002). Similar study in Top End of the 
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Northern Territory from 1989 to1998 revealed an average annual incidence rate of 16.5 
per 100, 000 population (Currie et al., 2000c). Recently an outbreak had been reported 
in Australia due to consumption of contaminated potable water supply (Inglis et al., 
1999, Currie et al., 2001, Dance, 2002). Following this outbreak, a thorough study was 
carried out to determine the effect chlorine treatment on B pseudomallei. The outcomes 
from the study showed that the bacteria had remarkable ability to survive in chlorinated 
potable water. Chlorine was found to have bacteriostatic effect on B. pseudomallei and 
the bacteria could be recovered from the treated water (Howard & Inglis, 2003b). 
 
At present, it has been estimated that 2000–5000 patients per year present with 
melioidosis in Thailand (Beeching et al., 2000, Leelarasamee, 2000, Dance, 2001). 
Several reports in the literature also pointed out that melioidosis might account for 29% 
of community-acquired septicemia and caused 40% of mortality among these patients in 
northeast Thailand (Dance et al., 1989a). The northeastern Thailand comprising of Ubon 
Ratchatani and Khon Kaen were recognised as the main endemic regions for 
melioidosis. Parotid abscess was the most common feature of melioidosis among the 
children in Thailand (Dance et al., 1989a). The seroepidemiological survey in 
northeastern Thailand revealed the presence of background immunity to melioidosis in 
80% of children born by the age of 4 years (Leelarasamee, 1998). 
 
In Singapore several exceptional features beside the common features found in Thailand 
and Australia have been reported. During the study period of 1987 and 1994, a total of 
23 cases of melioidosis were reported in apparently healthy military personnel with four 
deaths (Lim et al., 1997). In a separate study for the duration of 1989 to 1996 an 
alarming number of cases were also found in the community with disregard of their 
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professional and social status (Heng et al., 1998). Every one in the community was 
found to have potential to succumb to melioidosis. During this period a total number of 
372 cases were reported with 147 fatalities. The reported case fatality was alarming and 
considered much higher than total case fatality due to other common infectious diseases 
such as dengue fever, malaria, cholera and chicken pox. The exceptional features of 
melioidosis that were noted in Singapore included no correlation with well-recognized 
risk factors and rainfall. The disease occurred throughout the year and was not confined 
to any specific region. The overall incidence rates reported from epidemiological studies 
ranged from 1.7 to 2.4 per 100,000 population (Heng et al., 1998, Goh, 2001). 
 
1.3 Epidemiology of melioidosis in Malaysia 
 
Historical document showed that Stanton and Fletcher pioneered the early work of 
human melioidosis in 1913 in Malaysia. Following that several seroepidemiological 
investigations documented in the medical literature that described in detail the high 
prevalence of melioidosis in many parts of the country (Sanford & Moore, 1971, Dance, 
2000c). The reported epidemiological investigation pointed out the high prevalence of 
infection in the normal subjects. Moreover, melioidosis has been a well-recognised 
problem in the livestock industry. Several incidences of melioidosis in animals have 
been well documented by the Department of Veterinary Services, Ministry of 
Agriculture Malaysia (Mustaffa Babjee & Nor Aidah, 1994). However, the exact 
prevalence and incidence of melioidosis in human, and the true mortality rate have been 
difficult to establish for several reasons. There is no standardized statutory reporting of 
cases and melioidosis is not a in the list of notifiable disease. Owing to the high 
mortality rate, many fatal septicaemia cases could be due to melioidosis that remained 
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underdiagnosed. However, awareness regarding melioidosis in the community of 
infectious disease specialists, microbiologists and other healthcare workers leave much 
to be desired. In a thorough review on 50 cases of melioidosis admitted to a local 
Hospital, Puthucheary et al. (1992) clearly indicated the protean nature of the disease 
associated with high rate of mortality. She estimated that 15% to 20% of the Malaysian 
population has been infected with this bacterium (Oorjitham, 1998). 
 
Recent reports in the literature has been shown an increase in the number of melioidosis 
cases in Malaysia (Yee et al., 1988, Puthucheary et al., 1992, Chang & Francis, 1994, 
Halder et al., 1998, Puthucheary et al., 2001). 
 
1.4 General characteristics of B. pseudomallei 
 
1.4.1 Classification 
 
The genus Burkholderia has had a notable taxonomic history. Since its first description 
by A Whitmore in 1911, the status of the taxonomy and nomenclature of this bacterium 
has undergone considerable changes with multiple nomenclature schemes. The first 
name given by A. Whitmore was Bacillus pseudomallei (Howe et al., 1971). 
Subsequently, several combinations of names were assigned to this bacterium, which 
included Bacillus pseudomallei, Bacterium whitmori, Malleomyces pseudomallei, 
Loefflerella pseudomallei, and Pseudomonas pseudomallei. Subsequently the organism 
was classified under the genus Pseudomonas that consists of five major groups based on 
rRNA-DNA homology. This organism was grouped under rRNA group II together with 
three related species (Sanford, 1995). In 1992, the taxonomist introduced a major 
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amendment to the nomenclature of this bacterium that led to moving it and seven other 
related organisms under new genus known as Burkholderia and the proposed type 
species for the genus was Burkholderia cepacia. Most of the members of the genus are 
found in the plant environment and are often responsible for diseases in plants. This 
clear classification and amendment was introduced based on the 16s rRNA sequence 
homologies, DNA-DNA homology values, cellular lipid and fatty acid composition, and 
phenotypic characteristics (Yabuuchi et al., 1994). The new genus takes its name after 
the name of an American plant microbiologist, Walter Burkholder, to honor his pioneer 
work on Burkholderia cepacia that was responsible for onion rot. However, the newly 
assigned genus was continuously reviewed and had undergone considerable changes. In 
a recent publication, a comprehensive study on genetic relatedness among the species in 
the genus was established (Coenye et al., 2001). Following the restructuring exercise, 
the bacterium was officially named as B. pseudomallei and reassigned to the genus 
Burkholderia in the family Burkholdericeaea, a member of subdivision of the 
Proteobacteria. Currently, the genus Burkholderia is composed of a heterogeneous 
collection of 22 species of which most are plant pathogens. This classification and 
differentiation of species was based on phylogenetic analysis of 16S rRNA genes. 
Phylogenetic features of two species in the genus Burkholderia, namely B. mallei and B. 
thailandensis, are very closely related to B. pseudomallei (Woo et al., 2002, Godoy et 
al., 2003). B. thailandensis was originally reported in Thailand and assigned as a less 
virulent arabinose positive biotype of B. pseudomallei (Sonthayanon et al., 2002). After 
considerable debate and following an extensive genetic and phenotypic characterization 
the organism was renamed as B. thailandensis (Inglis et al., 2003). The less virulent 
nature and the ability to utilize arabinose are the most distinctive features of this 
bacterium that differentiated it with B. pseudomallei. 
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1.4.2 Bacteriology of B. pseudomallei 
 
B. pseudomallei is a Gram-negative, non-fermentative, non-sporing, capsulated, 
intracellular and motile bacterium. It can be seen singly, in pairs and occasionally in 
chains. The bacterium is non-fastidious, nutritionally versatile and able to grow well in 
any general basal medium. It is a free-living ubiquitous soil saprophyte found widely 
distributed in the natural environment in the endemic regions. 
 
The most common natural niches associated with this bacterium include the surface 
water, streams, stagnant pond, ground water, damp soil, paddy field, play ground, 
rubber plantation, palm oil plantation, plants, including commonly consumed 
vegetables, newly cleared land and construction ground. It can be isolated from soil 
source at a depth ranging from 20 to 60 cm in endemic areas. During dry weather the 
organism can often persist for prolonged periods in clay layers of soil in the endemic 
areas without any form of nutrient (Dance, 1991b, Dance, 2000b, Inglis et al., 2001). 
Findings from an in vitro experiment have shown the ability of this organism to 
penetrate and survive in free-living protozoa like acanthamoeba that are often present in 
collections of water. This observation indicates the possibility for a similar interaction 
that contributes to survival of B. pseudomallei in the environment and potential source 
for human infection (Inglis et al., 2000). 
 
The bacterium was also reported to have remarkable ability to survive for several years 
in nutrient limiting moist soil and water in tropical regions. It is also able to tolerate a 
range of deleterious environmental conditions such as effects of high acidic pH, 
freezing, drying, heat and currently practiced standard disinfection procedure for 
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potable water treatment.  However, the bacteria are readily killed by a variety of 
disinfectants such as sodium hypochlorite at 500 ppm chlorine or 5% phenol with 10-15 
minutes minimum exposure time. 
 
Typical wrinkling colony morphology on the culture media can be seen after 48 hours 
of incubation. However, colony variation can be observed in culture, which include 
presence of small round and mucoid colonies or mixed population of small greyish and 
typical wrinkled colonies. The presence of atypical colony morphology that resembled 
the colony morphology of many other Gram-negative bacteria have been reported 
(Haussler et al., 1999). Therefore, isolation of the bacteria from clinical specimens can 
be challenging due to colony variation. The organism can grow at 42°C and has the 
ability to survive at 4°C (Yabuuchi & Arakawa, 1993). Wide range of sugars and amino 
acid are utilised by the bacteria by oxidative or proteolytic reactions, respectively. 
Within the genus Burkholderia, the individual species can be differentiated on the basis 
of the physiological and biochemical reactions listed in table 1.1. These biochemical 
reaction properties are used in the routine laboratory identification of the bacteria. The 
important physiochemical properties used for identification of the culture isolate include 
ability to grow at 42°C, positive oxidase test, positive catalase test and production of 
nitrite and nitrogen gas from reduction of nitrate. Additional diagnostic tests for positive 
identification of the B. pseudomallei include positive Simmon’s citrate reaction, non-
fermentative reaction in TSI, resistance to polymyxin, colistin and aminoglycoside.  
 
The whole genome sequencing task was carried out at The Wellcome Trust Sanger 
Institute (http://www.sanger.ac.uk/Projects/B_pseudomallei/).  
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Table 1.1 Biochemical reactions for identification and differentiation of B. 
pseudomallei from the related species in the genus Burkholderia. Adapted from Zysk et. 
al. (2000). 
 
 Compound B. pseudomallei B. mallei B. cepacia B. vietnamensis B. gladiolii
 Ri
 L
 2-
 L
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 Gl
 Tr
 
E
D-
 Mesocona
I
 Gl
 Hi
 m
bose + - + d +
D-Xylose - + d + +
-Arabinose* - d + + +
n-Valerat + - + + +
Aminobenzoate - - + + +
Malonate - d + d +
-Citrulline - - + d d
Amylamine + - + d -
alicin + d + d -
Pimelate d d + - d
ycolate - - + - d
Citroconate - - + - d
yptamine - - + - -
rythritol + - - - -
Tartrate - - - - +
te - - - - +
taconate - - - + -
ycine - + - - -
L-Tartrate - - d - +
stamine - - d + -
Sucrose + + d + -
eso-Tartrate - - d d +
Maltose + d d - -
 
Abbreviation used in the table: +/-, more / less than 90% of the isolate yield a positive / 
negative reaction; d, between 10 to 90% of the isolates gave positive reactions; *, 
differentiates B. pseudomallei (-) and B. thailandensis (+). 
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In 2001, the sequencing process of the entire chromosomes of the B. pseudomallei was 
completed. The complete sequencing analysis was performed using the genomic 
material extracted from wild strain, K96243, a clinical isolate from Thailand. The 
genome size of the bacterium was estimated to be approximately 6 Mb comprising of 
two separate circular chromosomes with the size of 3.5 and 2.5 Mb, respectively 
(Songsivilai & Dharakul, 2000). Following successful completion of the whole 
genomes sequencing process of the bacterium, currently annotation work is being 
carried out at the centre (Sanger-Institute, 2001). Preliminary analysis of the complete 
genome sequences showed the presence of 1,041 open reading frames (ORFs). The 
genomes were also identified to be rich with guanine (G) and cytosine (C), which 
comprised of approximately 65% of the total genomes. 
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1.5 Mode of transmission 
 
Melioidosis is a soil and water-borne disease and the well-documented mode of 
infection in human is through direct contact of injured skin or mucous membrane with 
contaminated soil or water (Chaowagul et al., 1989, Dance, 2000a). Direct contact with 
infected livestock also has been proposed as source of infection especially to the 
abattoir workers. Furthermore, there are several reported cases of melioidosis in human 
that were acquired by other modes. These include documented cases of melioidosis 
infection acquired through respiratory route, ingestion, sexual and human-to-human 
contact (Achana et al., 1985, Lee et al., 1985, Kunakorn et al., 1991, Abbink et al., 
2001, Currie et al., 2001). 
 
Those at risk of acquiring the infection are agricultural workers, plantation workers, 
farmers, construction workers, military personnel, gardeners, log cutters, abattoir 
workers and laboratory staff handling specimen. The epidemiological studies conducted 
in Australia and Thailand revealed that the seasonal peak of melioidosis were during or 
immediately after the rainy period (Inglis et al., 2001, Currie & Jacups, 2003). 
 
1.6 Clinical manifestations 
 
Melioidosis is a progressive fatal infectious disease that imitates many other acute or 
chronic infectious diseases. The clinical presentations are extremely variable that can 
involve any organ system of the infected individual unlike a typical presentation 
commonly associated with many clinically important infectious diseases (Leelarasamee, 
1998, Dharakul & Songsivilai, 1999). Therefore, many synonyms have been attributed 
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to this disease, which includes the great imitator, living time bomb, medical time bomb, 
Vietnam time bomb, Vietnam tuberculosis and silent killer. For these reasons, the 
definitive diagnosis based on clinical presentations is frequently difficult to establish. 
The outcome of infection is unpredictable and multiple host-related factors and 
properties of the infecting pathogen contribute to disease progression from mild flu-like 
infection to a rapid fatal septicaemia associated with widespread infection throughout 
the body. Despite the unpredictable clinical outcome of melioidosis, several reports 
quoted in the medical text and literature described an attempt to classify the clinical 
features of the disease (Sanford, 1995, Dance, 2001).  Four main arbitrarily classified 
possible clinical consequences include asymptomatic subclinical infection, acute 
localized or widespread infection, subacute infection and chronic forms of infection (Ip 
et al., 1995, Dance, 1996). However, as mentioned earlier, frequent overlap of all forms 
of clinical disease does occur. One form of disease may progress to another, and 
infections may present acutely with rapid progression to death or mild infection with 
chronic on going course associated with late sudden onset. 
 
There are accumulating numbers of reports in the medical literature implicating several 
other anatomical sites with melioidosis which include skin, subcutaneous tissues, 
kidney, bones, joints, liver, spleen, brain, parotid glands, lymph nodes, pericardium, 
central nervous system, prostate gland, gastrointestinal system, musculoskeletal system 
and upper respiratory system (Woods et al., 1992, Halder et al., 1998, Currie et al., 
2000b, Karcher et al., 2000, Edmond et al., 2001, Tsang & Lai, 2001) Even though 
every vital organ can be infected but high tropisms to lungs have been indicated as a 
common feature of melioidosis. 
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The subclinical category of melioidosis represents the most common form of outcome 
encountered in a healthy individual that is often self-resolving. An infection in a healthy 
individual is usually associated with mild non-specific flu-like symptom and is often 
unrecognized. Majority of the infection occurring within the community in endemic 
regions fall in this category. Infected individuals in subclinical stage have circulating 
antibody. This complicates the interpretation of the serological tests. Several 
epidemiological studies have shown high rates of seroprevalence of melioidosis in 
endemic regions. A seroprevalence study conducted in Thailand showed the presence of 
antibody to melioidosis in 80% of the studied population comprising of children by the 
age of 4 years (Leelarasamee, 1998). 
 
The acute form of melioidosis infection is characterised by three basic patterns, 
localised infection, pulmonary infection and disseminated acute septicaemia. Localized 
skin infections is characterized by the presence of abscesses, cellulitis and nodular form 
of skin infection that can spread to regional lymph nodes causing lymphadenitis and 
subsequent spread to organs such as the liver, spleen and lung. Other presenting features 
of the skin infection include persistent ulcers or sores that fail to heal and painful 
localized cutaneous nodular abscess at the site of infection.  
 
Lung infection was the most common form of presentation of acute melioidosis that can 
give rise to a mild bronchitis to severe pneumonia. There are several unresolved non-
specific clinical presentation often associated with this form of infection. These include 
unexplained fevers, weight loss, fatigue, cough, shortness of breath, headache, anorexia, 
and general muscle soreness. Chest pain is common, with a non-productive or 
productive cough. This may be confused with tuberculosis. 
 16
The more severe forms of melioidosis are often seen among people with underlying 
conditions that compromise the immune system. These conditions include diabetes, 
alcoholism, cancer, advanced age and chronic liver, kidney or lung disease. Drugs used 
to treat cancer and long-term steroid therapy can also impair the immune system. 
Disease in the infected individual with the underlying risk factors can progress from 
mild flu-like symptoms to fatal septicaemia associated with broad-spectrum of clinical 
diseases involving multi-organ systems. Non-specific symptoms can vary depending on 
the stage and severity of the infection. Any form of the infection can progress to fatal 
septicaemia with pyogenic abscesses involving multi-organ system and there is no 
definitive distinction of the disease stages (Howe et al., 1971). The wide range of 
clinical presentations of acute melioidosis often resemble the symptoms of many other 
acute infections such as leptospirosis, typhoid fever, dengue fever, typhus, malaria, 
influenza, amebiasis, viral hepatitis, SARS (Bouadma et al., 2003) and other infectious 
diseases commonly encountered in the tropical regions (Currie et al., 2000a, White, 
2003). High incidence of acute parotid abscess in apparently normal children was 
documented  as a notable presenting feature in paediatric acute melioidosis cases in 
Thailand (Dance et al., 1989a, White, 2003). The mortality rate of improperly treated 
acute septicaemia cases can be as high as 70–80%.  
 
Subacute form of melioidosis is a progressive ongoing infection characterised by 
prolonged illness with or without fever associated with the presence of widespread 
multiple abscesses in almost every internal organs system with notable high tropism to 
respiratory system. The fourth category of clinical manifestation is chronic melioidosis 
which is the long standing suppurative abscess of internal organs system and the second 
most common presentation after the subclinical melioidosis. The clinical presentations 
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of chronic melioidosis are similar to the subacute infection but characterised by much 
longer incubation period than subacute infection in producing the clinical 
manifestations and may remain undetected for a number of years. The chronic form of 
melioidosis generally remains undiagnosed with minimum symptoms for many years 
until activated by a traumatic event or the presence of late-onset underlying diseases that 
impair the immune system. 
 
1.7 Pathogenesis 
 
The knowledge concerning pathogenesis and determinants of the disease severity for 
melioidosis are still scarce. The exact disease processes of melioidosis are yet to be 
defined clearly. Extensive research was engaged by many scientists throughout the 
world seeking new insights to the possible virulence determinant involved in the 
mechanism of the disease. Several animal models that resemble human melioidosis 
have been used to elucidate the pathogenesis of melioidosis (Hoppe et al., 1999, Ulett et 
al., 2001, Woods, 2002). Among the virulence factors implicated include the presence 
of flagella, capsular polysaccharide, extracellular proteases, endotoxin, exotoxin, 
haemolysin, lipase, acid phosphatase, siderophore, and presence of Type II O 
polysaccharide antigen that confer serum resistance to B. pseudomallei (Yang et al., 
1991, DeShazer et al., 1998, Woods et al., 1999, Brett & Woods, 2000, Lee & Liu, 
2000, Reckseidler et al., 2001, Chua et al., 2003). 
 
Similar studies were also reported that B. pseudomallei has the ability to penetrate, 
survive and multiply within not only in the professional phagocytes but also in virtually 
every nucleated cell of the body that enabled the infecting bacteria to cause wide spread 
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disseminated infection (Pruksachartvuthi et al., 1990, Egan & Gordon, 1996, Jones et 
al., 1996, Inglis et al., 2000). The bacterium was found to adapt the type III secretion 
system to invade the host cell as well as to break out of the phagocytic vacuole to 
escape into the cytosol (Winstanley & Hart, 2000, Rainbow et al., 2002, Stevens et al., 
2002). The type III secretion system is a well-characterised mechanism used by 
common pathogens such as Salmonella, Yersinia and Shigella to invade and damage the 
target cell by delivering the virulence factor straight into the host cell (Ehrbar et al., 
2003, Pujol & Bliska, 2003, Taniya et al., 2003, Waterman & Holden, 2003). Once in 
the cytosol, the bacterium was found to induce polymerization of actin from the host 
cell cytoskeleton to form actin filaments at one end of the bacterium This newly formed 
actin filament act like a driving force to push the bacterium against the host cell 
membrane which may protrude the cell surface and allow the bacteria to disseminate 
from cell to cell (Kespichayawattana et al., 2000). This remarkable ability allows the 
bacteria to spread into the deeper tissues and lay dormant in the body for many years 
before recrudesce into an acute fatal infection. Additional virulence factors such as a 
capsular polysaccharide and low pH tolerance allows the bacteria to survive and lay 
dormant in the phagocytic cell for a prolonged period. In addition, chronic diseases such 
as diabetes, renal disease and malignancy contribute to decreased function of phagocytic 
cell which lead to vigorous intracellular growth that may trigger extensive 
immunopathological reactions that lead to severe clinical conditions in the susceptible 
host. 
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1.8 Differential diagnosis 
 
The protean features of melioidosis made it difficult for its prompt diagnosis on clinical 
and laboratory ground. This has lead to melioidosis being named as the great imitator of 
many other infectious diseases. The confounding features include lack of distinctive 
clinical symptoms, the possible sudden onset of the clinical conditions, protean clinical 
manifestations, potential involvement of virtually any organ system with frequent 
unusual presentations and concurrent occurrence of melioidosis along with other 
diseases (Leelarasamee, 1998). Difficulties in laboratory diagnosis include low isolation 
rate, atypical colony morphology that often resemble colony morphology of other 
common bacteria, rapid overgrowth by normal flora and difficulties in accurate 
identification of culture isolate. Therefore, melioidosis must be considered in the 
differential diagnosis of a patient presenting with any febrile illness of unknown origin, 
multiple pustular skin or subcutaneous lesions, severe respiratory failure or when there 
is a chest x-ray pattern suggestive of tuberculosis but negative for acid-fast bacilli. A 
high index of suspicion and awareness are essential for early identification of potential 
cases of melioidosis particularly in patients presenting with the well-recognized risk 
factors or with a history of travel to or returning from well-known endemic regions. 
 
1.9 Antimicrobial treatment and prognosis 
 
Treatment of the disease poses considerable problems and is not a straightforward 
process like treatment for other common infectious diseases (Chaowagul, 2000). 
Furthermore, treatment and management of the disease are expensive, problematic, 
challenging and often annoying. Several studies have been reported regarding the 
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efficacy of antibiotic treatment and selection of a proper choice of antibiotic 
combination (Chetchotisakd et al., 2001b, Apisarnthanarak & Little, 2002). It is a well-
known fact that B. pseudomallei is innately resistant to penicillin, first and second 
generation of cephalosporins and aminoglycosides. In areas where melioidosis is 
endemic, the common empirical regimens that contain penicillin and gentamicin for the 
treatment of severe community-acquired pneumonia or septicaemia may not be 
appropriate. 
 
In contrast to treatment for other common bacterial infections, treatment for the 
confirmed case of melioidosis comprised of two stages which include acute phase 
treatment and convalescent phase (eradication treatment). To some extent, the treatment 
protocol is comparable with treatment approach in tuberculosis. Initial stage involved 
treatment of acute infection for a minimum duration of two weeks but for more severe 
infection longer duration of treatment is required. Surgical procedure should be 
exercised whenever possible to drain abscesses. Patient recovered from acute infection 
must be put on an eradication treatment. To date, there is continuous debate over the 
best approach to convalescent and maintenance therapy to prevent recurrent infection 
(Simpson et al., 1999, Simpson & White, 1999, Jenney et al., 2001). No precise 
treatment guideline can be advocated for each category of clinical disease of 
melioidosis.  Duration for eradication treatment can vary from 3 to 9 months depending 
on severity and clinical presentations during the acute infection. 
 
Current recommendations for therapy of severe melioidosis include intravenous 
ceftazidime or imipenem for 10 days to 4 weeks, followed by eradication therapy with 
oral amoxicillin-clavulanate (Augmentin), or a combination of trimethoprim-
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sulfamethoxazole and doxycycline for 10 to 18 weeks (White et al., 1989, Chaowagul et 
al., 1999, Chaowagul, 2000, White, 2003). However, the published reviews in the 
scientific literature recommended combination of four types of antibiotic regimens for 
effective eradication (Chaowagul et al., 1999, Suputtamongkol et al., 1999, 
Chetchotisakd et al., 2001a, White, 2003). The four antibiotic regimens comprised of 
chloramphenicol, doxycycline and trimethoprim-sulfamethoxazle. However, for 
pregnant patients and children, chloramphenicol is contraindicated and the best option is 
amoxicillin-clavulanate (Augmentin). 
 
Although the infection can be treated with readily available antibiotics but it is usually 
hard to achieve total elimination. Relapse, recrudescence, reinfection and reactivation 
are the common features of melioidosis (Chaowagul et al., 1993). Despite complete 
optimal treatment, the prognosis is still poor. The overall mortality is 40% in severe 
melioidosis but varies depending on cases. It is greater than 50% for septicaemic 
disease and 20% for localized disease (Currie et al., 2000c, Cheng et al., 2003). High 
rate of relapse was attributed to persistence of intracellular infections that impede the 
treatment efficacy. Furthermore, ceftazidime, the antibiotic of choice for melioidosis is 
unable to kill the non-replicating cell of bacteria lying dormant in the phagocytic cell 
due to its poor cellular penetration. 
 
A common problem arising from any treatment protocol prescribed for prolonged 
period is the emergence of resistant strain. Melioidosis belongs to this category of 
infectious diseases, therefore antibiotic resistance associated with treatment is another 
dilemma in patient management (Dance et al., 1989b, Ho et al., 2002, Tribuddharat et 
al., 2003). The emergence of resistant strain of B. pseudomallei to ceftazidime during 
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treatment has been previously reported (Tribuddharat et al., 2003). Hence, it has been 
noted in the literature that all confirmed cases of melioidosis require life long 
monitoring to detect emergence of resistant strain and clinical condition of the patient 
(Chaowagul, 1996, Jenney et al., 2001). 
 
1.10 Prevention 
 
Currently there is no vaccine available for melioidosis (Brett & Woods, 2000). The 
disease is largely acquired through exposure to the environmental factors such as soil, 
water and vegetation (Heng et al., 1998). Since the bacteria are widely distributed in the 
endemic areas prevention of the infection in such an environment have proven to be 
difficult. These have been indicated by several numbers of seroepidemiological studies 
that showed the presence of antibody to melioidosis in a large number of the population 
residing in the endemic areas or individuals travelling to the endemic areas (Chaowagul 
et al., 1989, Currie et al., 2000c, Finkelstein et al., 2000, Yang, 2000, Riesland et al., 
2001, Dance, 2002). Several preventive measures have been proposed in the literature to 
contain the infection (Faa & Holt, 2002, ABC-News, 2004). These include a thorough 
body examination and cleaning after returning from outdoor activity in the endemic 
areas. Such a measure could reduce the risk of infection. Personal hygiene should never 
be neglected. Looking after personal hygiene practice is crucial and will greatly reduce 
the risk of getting infected especially in individuals associated with recognised risk 
factors. 
 
Public health education also plays an important role in educating the public regarding 
the danger of the disease. The relevant health authority should emphasize on disease 
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prevention and implement concerted efforts in educating the public regarding the 
disease. The public should have the knowledge about the disease including awareness of 
the potential risk factors. They should also seek medical attention if facing any non- 
resolving prolonged fever associated with unknown causes. In health care settings, 
universal precautions in handling blood and body fluid should be implemented to 
prevent transmission of the diseases in the hospital or laboratory environments. Printed 
posters can be distributed to the public. Message also can be disseminated through 
public media, health educational brochures and newspaper. 
 
1.11 Laboratory diagnosis 
 
1.11.1 Routine culture isolation and direct microscopic examination of clinical 
specimens 
 
Routine microbiological investigations in the laboratory diagnosis of melioidosis 
comprised of direct microscopic examination of Gram-stained smear of the clinical 
specimen and culture isolation of the organism. Gram-stained smear of various type of 
clinical specimens should be examined under direct microscopy. The presence of small 
Gram-negative rod-shaped organism with typical bipolar staining in direct microscopic 
examination should be considered as presumptive diagnostic indicator for melioidosis 
(Sanford, 1995, Walsh & Wuthiekanun, 1996). 
 
Culture technique remains as a cornerstone for establishing the definitive diagnosis of 
melioidosis. The bacteria can be isolated from various clinical specimens, which include 
blood, urine, body fluid, sputum, throat, wound, stool or any purulent exudates. The 
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